Recent Advances of Poly(ether-ether) and Poly(ether-ester) Block Copolymers in Biomedical Applications

Area of Science:

• Polymer Science and Biomaterials Engineering
• Nanotechnology and Drug Delivery
• Regenerative Medicine

Background:

• Poly(ether-ether) and poly(ether-ester) block copolymers have a proven track record in biomedical applications due to their safety and biocompatibility.
• FDA-approved excipients like Poly(ethylene glycol) highlight the established use of similar polymers in medicine.
• Recent advancements focus on novel block copolymers for sophisticated biomedical uses.

Purpose of the Study:

• To review the applications of poly(ether-ether) and poly(ether-ester) block copolymers in advanced biomedical systems.
• To focus on active targeting theranostic systems, gene delivery, and tissue engineering applications.
• To summarize recent advances and emerging trends in this field.

Main Methods:

• A structured literature search of bibliographic databases was conducted.
• Inclusion and exclusion criteria were applied to select relevant peer-reviewed reports.
• Literature was cataloged based on copolymer type and application (theranostics, gene delivery, tissue engineering).

Main Results:

• Commercial poly(ether-ether) copolymers are utilized as excipients in drug development.
• Biodegradable poly(ether-ester) diblock copolymers are effective for creating nanoparticulate theranostic systems.
• Functionalized block copolymers show potential for future biomedical nanotechnology applications.
• Environment-sensitive triblock or multiblock copolymers are suitable for gene delivery and tissue engineering.

Conclusions:

• Biodegradable, environment-sensitive, and targeted block copolymers are key for advanced biomedical applications.
• These copolymers are promising for developing effective treatments for various diseases.
• The reviewed materials are integral to active targeting theranostic systems, gene delivery, and tissue engineering.